Ximena A. Levander

1.1k total citations
35 papers, 539 citations indexed

About

Ximena A. Levander is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Hepatology. According to data from OpenAlex, Ximena A. Levander has authored 35 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 20 papers in Public Health, Environmental and Occupational Health and 7 papers in Hepatology. Recurrent topics in Ximena A. Levander's work include Opioid Use Disorder Treatment (16 papers), HIV, Drug Use, Sexual Risk (14 papers) and Substance Abuse Treatment and Outcomes (9 papers). Ximena A. Levander is often cited by papers focused on Opioid Use Disorder Treatment (16 papers), HIV, Drug Use, Sexual Risk (14 papers) and Substance Abuse Treatment and Outcomes (9 papers). Ximena A. Levander collaborates with scholars based in United States, Germany and Australia. Ximena A. Levander's co-authors include P. Todd Korthuis, Kenneth L. Morford, K. John McConnell, Jane M. Zhu, Kim Hoffman, Dennis McCarty, Sunny C. Lin, Honora Englander, Javier Ponce Terashima and Ryan Cook and has published in prestigious journals such as SHILAP Revista de lepidopterología, Free Radical Biology and Medicine and Journal of General Internal Medicine.

In The Last Decade

Ximena A. Levander

32 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ximena A. Levander United States 11 307 202 89 60 53 35 539
Donald Bourne United States 14 251 0.8× 158 0.8× 73 0.8× 151 2.5× 15 0.3× 30 509
Christina Briegleb United States 9 569 1.9× 564 2.8× 43 0.5× 100 1.7× 64 1.2× 13 930
Rachel Carmen Ceasar United States 11 206 0.7× 77 0.4× 67 0.8× 36 0.6× 8 0.2× 34 383
Monika Hanke Germany 14 209 0.7× 126 0.6× 20 0.2× 160 2.7× 18 0.3× 29 643
Elizabeth Magnan United States 13 311 1.0× 132 0.7× 185 2.1× 147 2.5× 7 0.1× 29 570
Aimee Moulin United States 11 201 0.7× 155 0.8× 39 0.4× 108 1.8× 5 0.1× 23 610
Lauren Gorfinkel United States 12 290 0.9× 203 1.0× 93 1.0× 67 1.1× 4 0.1× 21 470
Shikhar Shrestha United States 13 208 0.7× 128 0.6× 19 0.2× 78 1.3× 9 0.2× 37 501
Veronica Orléans France 13 184 0.6× 95 0.5× 20 0.2× 44 0.7× 6 0.1× 39 514
Elizabeth Hotham Australia 13 144 0.5× 112 0.6× 19 0.2× 139 2.3× 12 0.2× 36 527

Countries citing papers authored by Ximena A. Levander

Since Specialization
Citations

This map shows the geographic impact of Ximena A. Levander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ximena A. Levander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ximena A. Levander more than expected).

Fields of papers citing papers by Ximena A. Levander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ximena A. Levander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ximena A. Levander. The network helps show where Ximena A. Levander may publish in the future.

Co-authorship network of co-authors of Ximena A. Levander

This figure shows the co-authorship network connecting the top 25 collaborators of Ximena A. Levander. A scholar is included among the top collaborators of Ximena A. Levander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ximena A. Levander. Ximena A. Levander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alexander, Ian J., et al.. (2025). Hepatitis C Treatment Initiation During Hospitalization for People Who Use Drugs: A Narrative Review of the Literature. Open Forum Infectious Diseases. 12(6). ofaf237–ofaf237. 1 indexed citations
2.
3.
Wyte‐Lake, Tamar, Deborah J. Cohen, David Casey, et al.. (2024). Patients’ and Clinicians’ Experiences with In-person, Video, and Phone Modalities for Opioid Use Disorder Treatment: A Qualitative Study. Journal of General Internal Medicine. 39(12). 2179–2186. 3 indexed citations
4.
Levander, Ximena A., et al.. (2024). Slicing through silos: Development and evaluation of a hospital-based telehealth hepatitis C virus treatment program. International Journal of Drug Policy. 127. 104396–104396. 2 indexed citations
5.
Levander, Ximena A., et al.. (2024). Association of economic and racial segregation with restricted buprenorphine dispensing in U.S. community pharmacies. SHILAP Revista de lepidopterología. 12. 100255–100255. 2 indexed citations
6.
Chan, Brian, Ryan Cook, Ximena A. Levander, et al.. (2024). Buprenorphine discontinuation in telehealth-only treatment for opioid use disorder: A longitudinal cohort analysis. Journal of Substance Use and Addiction Treatment. 167. 209511–209511. 1 indexed citations
7.
Levander, Ximena A., Thomas Carmody, Ryan Cook, et al.. (2023). A gender‐based secondary analysis of the ADAPT‐2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial. Addiction. 118(7). 1320–1328. 1 indexed citations
8.
Cook, Ryan, Onyebuchi A. Arah, Keith Humphreys, et al.. (2023). Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations. Addiction Science & Clinical Practice. 18(1). 11–11. 10 indexed citations
9.
Baker, Robin, Ximena A. Levander, Suzan M. Walters, et al.. (2023). “I am not a junkie”: Social categorization and differentiation among people who use drugs. International Journal of Drug Policy. 114. 103999–103999. 9 indexed citations
10.
11.
Hoffman, Kim, Ximena A. Levander, Ryan Cook, et al.. (2022). Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis. Journal of Substance Abuse Treatment. 141. 108801–108801. 42 indexed citations
12.
Levander, Ximena A., et al.. (2021). COVID-19-Related Policy Changes for Methadone Take-Home Dosing: A Multistate Survey of Opioid Treatment Program Leadership. Substance Abuse. 43(1). 633–639. 33 indexed citations
13.
Irwin, Adriane N., et al.. (2021). Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden. Drug and Alcohol Dependence. 224. 108729–108729. 68 indexed citations
14.
King, Caroline, Ryan Cook, Brian Chan, et al.. (2021). A hepatitis C elimination model in healthcare for the homeless organization: A novel reflexive laboratory algorithm and equity assessment. International Journal of Drug Policy. 96. 103359–103359. 12 indexed citations
15.
Levander, Ximena A., et al.. (2021). Low-Threshold Buprenorphine via Community Partnerships and Telemedicine—Case Reports of Expanding Access to Addiction Treatment During COVID-19. Journal of Addiction Medicine. 16(1). e56–e58. 10 indexed citations
16.
Button, Dana, et al.. (2021). Low-dose Buprenorphine Initiation in Hospitalized Adults With Opioid Use Disorder: A Retrospective Cohort Analysis. Journal of Addiction Medicine. 16(2). e105–e111. 45 indexed citations
17.
Levander, Ximena A., et al.. (2021). “Sobriety equals getting rid of hepatitis C”: A qualitative study exploring the interplay of substance use disorder and hepatitis C among hospitalized adults. Journal of Substance Abuse Treatment. 127. 108337–108337. 6 indexed citations
18.
Levander, Ximena A., et al.. (2021). Utilising an access to care integrated framework to explore the perceptions of hepatitis C treatment of hospital-based interventions among people who use drugs. International Journal of Drug Policy. 96. 103356–103356. 5 indexed citations
19.
Levander, Ximena A., et al.. (2015). Care of Women Veterans. Medical Clinics of North America. 99(3). 651–662. 12 indexed citations
20.
Burk, Raymond F., Kristina E. Hill, Akihiro Nakayama, et al.. (2008). Selenium deficiency activates mouse liver Nrf2–ARE but vitamin E deficiency does not. Free Radical Biology and Medicine. 44(8). 1617–1623. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald Bourne Breakdown of academic impact, for papers by Christina Briegleb Breakdown of academic impact, for papers by Rachel Carmen Ceasar Breakdown of academic impact, for papers by Monika Hanke Breakdown of academic impact, for papers by Elizabeth Magnan Breakdown of academic impact, for papers by Aimee Moulin Breakdown of academic impact, for papers by Lauren Gorfinkel Breakdown of academic impact, for papers by Shikhar Shrestha Breakdown of academic impact, for papers by Veronica Orléans Breakdown of academic impact, for papers by Elizabeth Hotham
Rankless by CCL
2026